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Abstract
Background: Observational studies suggest that insomnia might be associated with an increased risk of depression
with inconsistent results. This study aimed at conducting a meta-analysis of prospective cohort studies to evaluate
the association between insomnia and the risk of depression.
Methods: Relevant cohort studies were comprehensively searched from the PubMed, Embase, Web of Science, and
China National Knowledge Infrastructure databases (up to October 2014) and from the reference lists of retrieved
articles. A random-effects model was used to calculate the pooled risk estimates and 95 % confidence intervals
(CIs). The I2 statistic was used to assess the heterogeneity and potential sources of heterogeneity were assessed
with meta-regression. The potential publication bias was explored by using funnel plots, Egger’s test, and Duval
and Tweedie trim-and-fill methods.
Results: Thirty-four cohort studies involving 172,077 participants were included in this meta-analysis with an
average follow-up period of 60.4 months (ranging from 3.5 to 408). Statistical analysis suggested a positive
relationship between insomnia and depression, the pooled RR was 2.27 (95 % CI: 1.89–2.71), and a high
heterogeneity was observed (I2 = 92.6 %, P < 0.001). Visual inspection of the funnel plot revealed some
asymmetry. The Egger’s test identified evidence of substantial publication bias (P <0.05), but correction for
this bias using trim-and-fill method did not alter the combined risk estimates.
Conclusions: This meta-analysis indicates that insomnia is significantly associated with an increased risk of
depression, which has implications for the prevention of depression in non-depressed individuals with insomnia
symptoms.
Keywords: Insomnia, Sleep disorders, Depression, Meta-analysis, Epidemiology
Background
Depression is a common mental disorder and is de-
scribed as a continuum ranging from a few depressive
symptoms to major depression [1]. It is one of the
leading global burdens of disease (GBD) and is esti-
mated to be one of the top three health concerns by
2020 [2, 3]. Some evidence showed that 5.8 % of men
and 9.5 % of women would experience a depressive
episode in any given year for a lifetime [4]. Among
older adults in Japan, depression is one of the most
common diseases and is a leading cause of morbidity
and mortality [5, 6].
Insomnia is the subjective feeling of having difficulties
initiating or maintaining sleep (DIS and DMS respect-
ively, jointly referred to as DIMS) or of non-restorative
sleep (NRS) [7, 8]. Epidemiological studies have shown
that 20 to 35 % of the general population report insom-
nia symptoms, and that 10 to 20 % have clinically signifi-
cant insomnia syndrome [9–13]. Insomnia prevalence
has been found to be associated with measurements of
worse physical and mental health [14].
Both insomnia and depression are major public
health problems. It has been reported that insomnia is
associated with an increased risk of depression and/or
anxiety disorders [9, 15]. The identification of modifi-
able risk factors for depression has a greatly important
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implication for the primary prevention. Many observa-
tional studies have focused on whether insomnia has an
influence on depression risk [9, 16–23]. In 2011,
Baglioni et al. [24] performed a meta-analysis to inves-
tigate the association between insomnia and the risk of
depression, and the results showed that an overall odds
ratio (OR) for insomnia to predict depression of 2.60
(95 % confidence interval (CI):1.98–3.42). Since then,
many new observational studies have emerged, and
some of them had large sample sizes and long follow-
up lengths. In addition, the previous review only con-
ducted a subgroup analysis by different age groups of
participants. The incidences and the risk factors for
depression might vary with the definitions of depres-
sion and the exposure changes, or vary in samples
from different gender, follow-up durations, and geo-
graphic regions. Including more studies and enlarging
the sample size would be important for strengthening
the reliability of describing the association between in-
somnia and depression risk. Therefore, we conducted
an updated-analysis to further investigate the issue.
Methods
Search strategy
This meta-analysis was performed according to the check-
list of the Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) guidelines [25]. The systematic
literature search was conducted by two investigators
(L.Q.L. and C.M.W.) independently through the PubMed,
Embase, Web of Science and China National Knowledge
Infrastructure (CNKI) databases for pertinent studies
published in English and Chinese from their inception to
October 2014. The key words used as the search terms
were the following: “insomnia”, “sleep disorder”, “sleep
disturbance”, “sleep problem”, “sleep quality”,”sleep
duration” in combination with “depression”, “mental
disorder”, and “anxiety”. The search was restricted to
studies in humans. In addition, the reference lists of all
identified relevant publications were reviewed.
Inclusion criteria and exclusion criteria
The eligibility of each study was assessed independ-
ently by two investigators (L.Q.L. and C.M.W.), and
disagreements were resolved through consultation with
the third investigator (Z.X.L.). Studies meeting the fol-
lowing criteria were included in the meta-analysis: (1)
the main exposure of interest was insomnia and the
outcome of interest was depression; (2) the study design
was prospective cohort; (3) insomnia was characterized by
DIS and/or DMS or NRS; (4) depression was measured by
self-reported symptom scales, physician/clinician diagno-
sis, or structured clinical diagnostic interview [24]; and (5)
the study reported a ratio-based measurement of associ-
ation of insomnia with depression.
Studies were excluded if: (1) the study was not pub-
lished as the full reports, such as case reports, com-
mentaries, conference abstracts and letters to editors;
(2) the study had a retrospective design; (3) participants
with depression at baseline were not excluded for the ana-
lysis or the effect of symptoms of insomnia on predicting
depression was not controlled for other depressive symp-
toms at baseline [24]; and (4) Both insomnia and depres-
sion acted as the exposure resulting in predicting the
other disorder (such as anxiety). If duplicate publications
from the same study were identified, we would include the
result with the largest number of individuals from the
study.
Data extraction
The following information was extracted for each study:
name of the first author, publication year, study name,
source of the participants, geographic region, gender,
mean age of the participants at baseline, insomnia meas-
urement, definition of insomnia based on DSM-IV-TR cri-
teria [8], depression measurement, length of the follow-up
period, number of the follow-up assessments, sample size,
the OR, relative risk (RR) or hazard ratio (HR) with 95 %
CI, and covariates that were adjusted in the multivariable
analysis.
Quality assessment
Two investigators (C.M.W. and Y.G.) independently ful-
filled the quality assessment using the Newcastle-Ottawa
Scale [26], which is a validated scale for non-randomized
studies in meta-analysis. The Newcastle-Ottawa Scale is a
nine-point scale that allocates points on the basis of the
process of selection of the cohort study and measure-
ment of exposure (0–4 points), the comparability of co-
horts (0–2 points) and the identification of the
outcome and adequacy of follow-up (0–3 points). We
assigned scores of 0–3, 4–6, and 7–9 for the low, mod-
erate, and high quality of studies, respectively.
Statistical analysis
The RR was considered as the common measure of the
association between insomnia and depression. The HR
was considered to be equivalent to RR, and the OR was
transformed into the RR. OR was corrected according to
the following formula: RR ¼ OR1−P0ð Þþ P0ORð Þ [27]. In the
cohort study, P0 indicated the incidence of the outcome
of interest in the non-exposed group. We preferentially
pooled multivariable adjusted risk estimates where such
estimates were reported. Where adjusted analysis was
not available, we pooled the unadjusted estimates. The
RRs for the associations between insomnia and the risks
of depression were pooled using the fixed-effects model
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where heterogeneity was not detected, or the random-
effects model was used otherwise.
For further confirmation and assessment of the associ-
ation between insomnia and the risk of depression, sub-
group analysis was carried out to explore the sources of
potential heterogeneity and examine the robustness of the
primary results. The differences among subgroups were
tested by meta-regression analysis (using STATA ‘metareg’
command). In sensitivity analysis, we conducted a leave-
one-out analysis [28] to observe the magnitude of influ-
ence of each study on the pooled RR.
Statistical heterogeneity among studies was evaluated
with the Q and I2 statistics. For the Q statistic, statistical
significance was set at P < 0.1 and for the I2, the values
of 25 %, 50 % and 75 % respectively denoted cut-off
points for low, moderate and high degrees of heterogen-
eity [29]. Potential publication bias was evaluated with a
funnel plot and the Egger’s test [30]. The Duval and
Tweedie nonparametric trim-and-fill methods [31] were
performed to further assess the potential publication
bias. All statistical analyses were performed with STATA
statistical software (version 12.0; College Station, TX,
USA). All reported probabilities (P values) were two-




Figure 1 presents the process of this study selection. The
search strategy identified 4,802 articles, in which 4,185
articles from the PubMed, 355 articles from the Embase,
226 from the Web of Science, and 36 from the CNKI
were retrieved. Of these, based on abstracts or titles, the
majorities were excluded after the first screening be-
cause they were reviews, case reports, or not relevant to
our analysis. After full-text review of the remaining 89
studies, 55 studies were excluded for the reasons shown
in Fig. 1. Of note, all of the 21 studies included in the
previous review were eligible according to the criteria in
our research except two duplicated studies [7, 16] used
the same samples as the other two studies [20, 32], and
articles with longest follow-up and more detailed infor-
mation were retained. Thus, 34 eligible cohort studies
were finally included in this meta-analysis.
Characteristics of studies
The included 34 studies [9, 10, 17–23, 32–56] were pub-
lished between 1989 [9] and 2014 [32, 55, 56], and char-
acteristics of them are shown in Table 1. The sample
sizes of the cohorts ranged from 147 [40] to 44,270 [56]
with a total of 172,077. The length of follow-up duration
ranged from 3.5 [32] to 408 [18] months in this study,
with an average of 60.4 months. Fourteen studies were
conducted in the United States [9, 10, 17–19, 22, 23,
34–36, 38, 40, 51, 52] and in Europe [20, 32, 33, 37, 39,
41, 42, 45–47, 49, 50, 52, 53, 56] respectively, two stud-
ies in Australia [44, 55], and four studies in Asia [21,
43, 48, 54]. Three studies reported results for males
only [18, 44, 52], and three studies reported results
for females only [32, 46, 55], 27 studies reported re-
sults for both males and females [9, 10, 17, 19–23,
33–43, 45, 47–51, 53, 54, 56],and one study [47] re-
ported results for males and females separately. In the
present study, 11 studies [9, 10, 19–21, 32–34, 36, 38,
42, 46, 48, 52, 56] diagnosed insomnia on the basis of
all DSM- IV criteria [57]: sleep difficulties, duration
and daytime consequence (sd, dur and day), 10 stud-
ies [10, 23, 33, 34, 36, 47, 50, 51, 53, 54] based the
diagnosis only on sleep difficulties and duration cri-
teria (sd and dur), and 13 studies [17, 18, 22, 35, 37,
39, 40, 43–45, 49, 55] took into consideration only
the sleep difficulties criterion (sd) [24]. Ten studies
[18–20, 32, 45, 50, 51, 54, 55, 58] assessed insomnia
repeatedly during the course of the follow-up, and
the rest of the studies assessed insomnia at baseline.
Fig. 1 Flow chart of study selection of insomnia in relation
to depression
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Table 1 Characteristics of included studies in the meta-analysis


























sd§, dur† and day Diagnostic
Interview
Schedule
12 1 Range 18+;
mean 45.79
7,954 Age, sex, socioeconomic status,
race, and marital status




sd and dur Geriatric
Mental State
36 1 Range 65+;
mean 69.76
701 No covariate adjustment










42 1 Range 21–
30; mean
26.14
979 Sex, hypersomnia, and number
of other depressive symptoms










408 7 Range NA;
mean 26.3
941 Age at graduation, class year,
parental history of clinical
depression, coffee
consumption, and measures of
temperament











12 1 Range 18+;
mean 48.23
7,113 Age, sex, and site
Foley et al. 1999 USA
[35]
None M/F Interview sd CES-D 36 3 Range 65+;
mean 80.09
6,899 No covariate adjustment
Johnson et al. 2000
USA [36]
None M/F 1 item from
the CBCL
sd and dur CBCL and
TRF
60 1 Range NA;
mean 6
717 Sex, birth weight, and mother’s
history of MDD using
generalized estimation
equations






sd HADS 144 1 Range 45–
65; mean 55
1,244 Smoking, depression, and
insomnia









12 1 Range 50+;
mean 64.9
2,370 Age, sex, marital status, social
isolation, education, financial
problems, problems with daily
activities, and heave drinking
Roberts et al. 2002
USA [38]




12 1 Range 11–
17; mean 15
3,136 Age, values of the functioning
measures at baseline, sex,
parental education, and
insomnia level










60 1 Range 55+;
mean 60
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Perlis et al. 2006 USA
[40]




12 1 Range 60+;
mean 72
147 No covariate adjustment
Morphy et al. 2007
UK [41]
None M/F Jenkins Sleep
Scale
sd HADS 12 1 Range 18+;
mean 50
1,589 Age, sex, social class, anxiety
(except when anxiety is the
problem of interest), depression
(except when depression is the
problem of interest), and pain
areas (except when widespread
pain is the problem of interest)
Buysse et al. 2008
Switzerland [20]
The Zurich Study M/F SPIKE and
visual analogue
scales
sd, dur and day SPIKE 240 6 Range NA;
mean 19.5
278 Concurrent MDE at the time of
insomnia diagnosis
Cho et al. 2008 USA
[19]
Depression Substudy M/F PSQI sd, dur and day SCID and BDI 24 3 Range 60+;
mean 69
329 Group status, depression
symptoms, medical disease,





















sd and dur In-home
interview
78 1 Range 12–
18; mean 16
3,582 Sex




M/F Interview sd, dur and day Geriatric
Mental State
24 1 Range 65+;
mean 72.2
792 Age, sex, education, housing,
past occupation, current
employment, living area, life
events, social deficit, physical
activity, GMS organicity, GMS
anxiety, and daily drinking.












44 1 Range 33–
71; mean
53.6




use of hypnotic agents, and
BMI






M/F Questionnaire 11-item short
form of the
CES-D
36 1 Range 69+;
mean 73.1
3,065 Age, sex, educational history,
place of residence, sleep
duration, excessive daytime
sleepiness, discomfort feeling in
the legs, subjective sleep
sufficiency, psychological stress,
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sd CES-D 48 2 Range 65+;
mean ≥ 60
3,824 Age, center, CES-D baseline, sex,
education, living alone, coffee
consumption, alcohol consump-
tion, smoking, chronic disease,
past major depression, disability,
prescribed sleep medication in-
take, and homeopathic and
non-prescription treatments for
sleep
Almeida et al. 2011
Australia [44]
Health In Men Study
(HIMS)




72 1 Range 70+;
mean ≥ 60
5,127 Age, education group, migrant
status, living alone, low social




disease, stroke, and cancer
Marques et al. 2011
Portugal [46]
None F Interview sd, dur and day DSM-IV 5 1 Range 18–
44; mean
29.8
382 Negative affect, positive affect,
and lifetime depression
Thomée et al. 2011
Sweden [47]












12 1 Range 20–
24; mean <
60
1,455 Relationship status, educational
level, and occupation
Okajima et al. 2012
Japan [48]
None M/F PSQI sd, dur and day CES-D 24 1 Range 20+;
mean 57.4
1,577 Age, sex, disease currently
treated, habitual alcohol
ingestion, smoking habit, and
living alone











42 1 Range 19–
70; mean
43.9
40,791 Age, sex, socioeconomic
position, night/shift work,
health behaviors, baseline
physical health, use of pain
killers, psychological distress,
and anxiety















18 1 Range 16–
74; mean
44.75
2,406 Age, sex, marital status,
educational
qualifications,occupational class,
employment status, and other
psychological symptoms








sd and dur PHQ-9 84 2 Range NA;
mean 33.1
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M/F Questionnaire sd and dur BDI 72 3 Range 43–
73; mean
52.3
1,089 Age, sex, education level,
employment status, marital
status, physical health, smoking
status, heavy drinking, and time
interactions with each covariate






M PSQI sd, dur and day Geriatric
Depression
Scale (GDS)
40.8 1 Range 67+;
mean 75.9
2,352 Age, clinic site, baseline GDS
score, health status, education,
use of benzodiazepines, alcohol
consumption, cognitive
function, walks for exercise,
impairments in activities of
daily living and certain medical
conditions







sd and dur HADS 72 2 Range 50+;
mean ≥ 60
2,373 Age, sex, marital status,
employment status, alcohol
intake, smoking status, and BMI






F Questionnaire None (sleeping
difficulties in the
last 12 months)
Questionnaire 108 3 Range 22–
27; mean <
60
5,702 Education level, body weight
dissatisfaction, history of abuse,
and binge drinking in 2000




















rheumatoid arthritis, stroke and
whiplash at baseline.
Dørheim et al. 2014
Norway [32]
Akershus Birth Cohort F BIS sd, dur and day EPDS 3.5 2 Range 17.4–
47.5; mean
31.5
2,088 No covariate adjustment
Abbreviations: NA not available, F female, M male, NIHM National Institute of Mental Health, CES-D Centre for Epidemiologic Studies Depression, CBCL Child Behavior Checklist, EPDS Edinburgh Postnatal Depression
Scale, GMS Geriatric Mental State diagnostic schedule, TRF Teacher Report Form, HADS Hospital Anxiety and Depression Scale, DSM-12D 12-item scale for DSM depression, HAMD Hamilton Rating Scale for Depression,
SCID Structured Clinical Interview for DSM Disorders, SPIKE Structured Psychopathological Interview and Rating of Social Consequences of Psychic Disturbances for Epidemiology, PSQI Pittsburgh Sleep Quality Index,
BDI Beck Depression Inventory, BIS The Bergen Insomnia Scale, PSG polysomnographic assessment, day daytime consequences criterion











Table 2 Quality assessment of studiesa












at start of study
Comparability of
cohorts on the










Ford and Kamerow [9] 1 1 1 1 1 1 0 0 6
Brabbins et al. [33] 1 1 1 1 0 1 0 0 5
Breslau et al. [34] 1 1 1 1 1 1 0 1 7
Chang et al. [18] 1 1 1 1 2 1 1 1 9
Weissman et al. [10] 1 1 1 1 1 1 0 0 6
Foley et al. [35] 1 1 1 1 0 1 0 0 5
Johnson et al. [36] 1 1 0 1 1 1 1 1 7
Mallon et al. [37] 1 1 0 1 1 1 1 0 6
Roberts et al. [17] 1 1 0 1 0 1 0 1 5
Roberts et al. [38] 1 1 0 1 2 1 0 0 6
Hein et al. [39] 0 1 1 1 0 1 1 1 6
Perlis et al. [40] 0 1 1 1 0 1 0 0 4
Morphy et al. [41] 1 1 1 1 2 1 0 0 7
Buysse et al. [20] 1 1 1 1 1 1 1 0 7
Cho et al. [19] 1 1 1 1 2 1 0 1 8
Jansson-Fröjmark and
Lindblom [42]
1 1 1 1 1 1 0 1 7
Roane and Taylor [23] 1 1 1 1 0 1 1 0 5
Kim et al. [21] 1 1 1 1 2 1 0 0 7
Szklo-Coxe et al. [22] 1 1 1 1 1 1 0 0 6
Yokoyama et al. [43] 1 1 1 1 2 1 0 0 7
Jaussent et al. [45] 1 1 1 1 2 1 0 0 7
Almeida et al. [44] 1 1 1 1 2 1 1 0 8
Marques et al. [46] 0 1 0 1 1 1 0 0 4
Skapinakis et al. [53] 1 1 1 1 2 1 0 0 7
Salo et al. [49] 1 1 1 1 2 1 0 1 8
Suh et al. [54] 1 1 1 1 2 1 1 1 9
Paudel et al. [52] 1 1 1 1 2 1 0 0 7
Campbell et al. [50] 1 1 1 1 2 1 1 1 9










Table 2 Quality assessment of studiesa (Continued)
Sivertsen et al. [56] 1 1 1 1 2 1 1 1 9
Okajima et al. [48] 1 1 1 1 1 1 0 0 6
Thomée et al. [47] 0 1 1 1 1 1 0 0 5
Gehrman et al. [51] 0 1 1 1 2 1 1 0 7
Dørheim et al. [32] 0 1 1 0 0 1 0 0 3
aThe study quality was assessed according to the Newcastle Ottawa Quality assessment scale for cohort studies. This scale awards a maximum of 9 points to each study: 4 for selection, 2 for comparability, and 3 for










Interobserver agreement (κ) between two investigators
was 0.98. The results of quality assessment are shown in
Table 2. The average score for the quality assessment of
included cohort studies was 6.6 (of a possible 9 points),
which indicated that the quality for all studies was
moderate-high in a whole.
Quantitative synthesis
The results from the random-effects model combining
the RRs for depression in relation to insomnia are shown
in Fig. 2. Twenty-six studies suggested a significant posi-
tive relationship between insomnia and depression, while
the other studies did not. The pooled RR of depression
was 2.27 (95 % CI: 1.89–2.71) among populations with
insomnia, and a high heterogeneity was observed among
studies (I2 = 92.6 %, P < 0.001).
Subgroup analysis
Subgroup analysis was conducted by mean age at baseline,
sex, study location, insomnia definition, type of depression
measurement, follow-up duration, sample size, study qual-
ity, publication year (before 2010 vs. after 2010), and
whether age, socioeconomic status, smoking status, alco-
hol intake, body mass index (BMI) were controlled or not
in models. Insomnia was significantly associated with an
increased risk of depression in all subgroups, with the
exception of populations from Australia (RR = 1.79, 95 %
CI = 0.90–3.54, I2 = 95.9 %, P < 0.001). However, moderate
to high heterogeneities were observed. No interactions
Fig. 2 Forest plot of the association between insomnia and risk of depression
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Table 3 Subgroup analysis of relative risks for the association between insomnia and depression
No of studies RR (95 % CI) I2 (%) P value for heterogeneity P value between groups
Mean age at baseline, y
<60 22 2.50 (1.96, 3.20) 94.70 <0.001 0.31
≥60 12 1.87 (1.47, 2.37) 80.70 <0.001
Sex
Male 3 1.46 (1.13, 1.88) 26.70 0.256 0.48
Female 3 1.96 (1.05, 3.66) 73.50 <0.001
Mixed 28 2.41 (1.97, .95) 92.80 <0.001
Study location
USA 14 3.13 (2.03, 4.85) 89.80 <0.001 0.17
Europe 14 1.73 (1.43, 2.09) 88.50 <0.001
Asia 4 2.27 (1.22, 4.21) 90.40 <0.001
Australia 2 1.79 (0.90, 3.54) 95.90 <0.001
Source of participants*
General population 25 2.34 (1.85, 2.96) 94.00 <0.001 0.75
Non-general population 9 2.05 (1.53, 2.74) 78.70 <0.001
Insomnia definition
Sd, dur and day 11 2.90 (1.78, 4.74) 92.70 <0.001 0.37
Sd and dur 10 2.21 (1.50, 3.25) 90.30 <0.001
Sd 13 1.87 (1.53, 2.29) 87.70 <0.001
Type of depression measure
Self-reported scales 17 2.20 (1.70, 2.86) 94.10 <0.001 0.63
Physician diagnosis 15 2.27 (1.67, 3.09) 91.80 <0.001
Combined 2 3.89 (1.73, 8.74) 0.00 0.438
Follow-up duration, y
<5 22 2.34 (1.84, 2.97) 93.60 <0.001 0.77
5–10 8 2.37 (1.73, 3.25) 82.30 <0.001
>10 4 1.88 (1.52, 2.32) 54.60 0.086
Sample size
<5000 26 2.01 (1.66, 2.44) 86.50 <0.001 0.10
≥5000 8 3.12 (2.11, 4.62) 96.40 <0.001
Study quality
Score >7 8 2.06 (1.60, 2.63) 88.60 <0.001 0.70
Score≤ 7 26 2.36 (1.83, 3.03) 93.00 <0.001
Publication year
Before 2010 19 2.63 (1.95, 3.55) 88.20 <0.001 0.21
2010–2014 15 1.94 (1.53, 2.45) 94.62 <0.001
Statistical model
Unadjusted 5 1.78 (1.29, 2.47) 56.00 0.078 0.75
Adjusted 29 2.31 (1.90, 2.81) 93.40 <0.001
Controlling age in models
Yes 21 2.64 (2.04, 3.42) 92.30 <0.001 0.09
No 13 1.75 (1.33, 2.31) 92.50 <0.001
Controlling SES in models
Yes 17 2.34 (1.81, 3.03) 95.60 <0.001 0.78
Li et al. BMC Psychiatry  (2016) 16:375 Page 11 of 16
between insomnia and stratification variables in relation
to depression risk were observed (all P values for interac-
tions > 0.05; Table 3).
Sensitivity analysis
Sensitivity analyses were used to identify the potential
sources of heterogeneity in association between insom-
nia and the risk of depression. This helped to examine
the influence of various exclusions on the combined RR
and test the stability of the quantitative synthesis results.
In the leave-one-out analysis by omitting one study in
turn, the overall combined RR did not change substan-
tially, with a range from 2.07 (95 % CI: 1.77–2.42) to
2.33 (95 % CI: 1.95–2.78), and I2 varied from 89.6 to
89.9 %. This indicated that none of the individual studies
significantly influenced the overall result. It was worth
noting that, six studies [32, 38, 41, 49, 50, 54] defined in-
somnia as DIS and/or DMS or NRS, and the rest of
studies defined insomnia as DIS and/or DMS. There is
controversy as to whether individuals with NRS com-
plaint share similar pathophysiologic mechanisms with
the other nocturnal symptoms, such as DIS and DMS.
Restricting the analysis to the 28 studies defined insom-
nia as DIS and/or DMS yielded a pooled RR of 2.30
(95 % CI, 1.84 to 2.87) after exclusion of 6 studies. Thus,
our main results would not change even if these six
studies were excluded.
Publication bias
The visual inspection of the funnel plot identified sub-
stantial asymmetry (Fig. 3). The Egger’s test identified
evidence of substantial publication bias (P < 0.05). A sen-
sitivity analysis using the trim-and-fill method was
performed with 16 imputed studies, which produced a
symmetrical funnel plot (Fig. 4). Using the trim-and-fill
method, the RR was 1.40 (95 % CI, 1.16–1.69; P < 0.001).
Correction for potential publication bias thus did not
alter the significant association.
Discussion
The results of this meta-analysis of 34 prospective co-
hort studies showed that insomnia was significantly as-
sociated with an increased risk of depression. The
pooled estimates (RR = 2.27; 95 % CI: 1.89–2.71) indi-
cated that participants with insomnia, compared to
those free of it, experienced more than two-fold risk to
develop depression. Furthermore, the association
remained significant in most subgroup analyses.
Comparison with previous study
Our findings were approximately consistent with those
from the meta-analysis by Baglioni et al. in 2011 [24],
which also showed that sleep difficulty was significantly
associated with depression. The results of this current
meta-analysis generally concur and further complement
the findings of previous review in several important
aspects. The present meta-analysis included 15 new pro-
spective cohort studies with larger sample sizes and
many more cases, which significantly enhanced the stat-
istical power to detect potential association between in-
somnia and depression risk. Additionally, the previous
review did not investigate any subgroups other than age.
More importantly, compared with the previous review,
the OR was corrected to more approximately the true
RR in the present study, therefore our risk estimate is
more accurate and a reliable. Of note, the associations
differed among populations of different ethnic back-
grounds were investigated in the present study. The
current meta-analysis showed that the increased risk was
more pronounced for participants from the United
States than for European participants. However, no
statistically significant association was observed in
Table 3 Subgroup analysis of relative risks for the association between insomnia and depression (Continued)
No 17 2.15 (1.74, 2.65) 71.60 <0.001
Controlling smoking status in models
Yes 7 2.10 (1.45, 3.06) 89.80 <0.001 0.75
No 27 2.32 (1.88, 2.87) 93.30 <0.001
Controlling alcohol intake in models
Yes 9 2.47 (1.75, 3.48) 90.90 <0.001 0.69
No 25 2.19 (1.78, 2.69) 92.00 <0.001
Controlling BMI in models
Yes 5 2.19 (1.57, 3.06) 85.30 <0.001 0.94
No 29 2.28 (1.87, 2.78) 92.30 <0.001
Abbreviations: BMI body mass index, dur duration criterion, day daytime consequences criterion, F female, M male, NA not available, SES socioeconomic status, Sd
sleep difficulties criterion
*Study population truly or somewhat representative of a community or population-based study defined as general population, and study population was sampled
from a special population (such as population from a company, register patients, data from the health insurance company or health examination organization or
pregnant), which defined as non-general populations
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Australian populations, which might result from the lim-
ited number of included studies (two studies comprising
13,323 participants). In order to make the finding
generalize to other populations, more studies are war-
ranted to be conducted in other populations from Asia,
Africa and South America.
There were several possible biological mechanisms
through which insomnia in general may increase the
risk of depression. Sleep disturbance may play a key
role in the development of depression. Experimental
studies showed that sleep loss may result in cognitive
and affective alterations that lead to depression risk [55].
Alternatively, sleep disturbance impaired emotional regu-
lation and stability [59] and may alter neural processes
that may result in the symptomatology of depression
[60]. Secondly, sustained arousal and chronic activation
of hyperactivity of the hypothalamic–pituitary–adrenal
(HPA) axis, the major neuroendocrine mediator of
stress response, have been suggested as playing a vital
role in the development of depression in insomniacs
with objective short sleep duration [14, 61]. Finally,
other proposed mechanisms by which insomnia might
Fig. 3 Funnel plot with pseudo 95 % confidence limits of insomnia and depression. The horizontal line represents the summary effect estimates,
and the dotted lines are pseudo 95 % CIs
Fig. 4 Filled funnel plot of RR from studies that investigated the association between insomnia and the risk of depression. The circles alone are
real studies and the circles enclosed in boxes are ‘filled’ studies. The horizontal line represents the summary effect estimates, and the diagonal
lines represent pseudo-95 % CI limits
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increase the risk of depression included increasing
levels of inflammatory markers, such as C-reactive pro-
tein and interleukin-6 (IL-6) [62–64], which indicated
low-level systemic inflammation was a predictor of de-
pression development [65].
Long-term, double-blind, randomized controlled trials
provided the best evidence on the effect between insom-
nia and depression. Recently, the study by Gosling et al.
[66] showed that an internet-based insomnia interven-
tion would indeed reduce the risk of depression. The
role of insomnia treatment in modulating subsequent
risk of depression needs to be studied further.
Strengths and limitations
Our review is very valuable and crucial though it is an
updated meta-analysis. First, our review added more
than 3 times as many participants as the previous re-
view, which provided stronger and more sufficient evi-
dence. Second, the prospective nature of the included
studies avoided the influence of recall and selection bias.
Third, more studies from additional areas other than the
North America and Europe were included, which in-
creased the generalizability. Fourth, we did stratified
analyses to explore whether the results were influenced
by some confounding factors, and the consistent results
from the sensitivity and subgroup analyses indicated that
our findings were reliable and robust.
There are also some limitations in this meta-analysis.
Firstly, the accuracy of our results might be influenced
by the differences of the measurement criteria of insom-
nia and depression. However, no significant differences
among groups were observed for the type of insomnia
and depression measurement in this study. Secondly, we
were unable to independently summarize the evidence
of individual types of insomnia symptoms on depression
risk due to no sufficient information in the original
studies. Thirdly, although we extracted the most fully
adjusted risk estimates, the adjusted confounders varied
among the included studies. Some important confound-
ing factors that might influence the relationship between
insomnia and depression risk were gender, age, smoking,
education, alcohol or drug abuse, other somatic or psy-
chiatric disease, medication status, and social status.
These important confounders were not fully adjusted in
some of the included studies, which might influence the
accuracy of the results. Finally, publication bias were de-
tected, however, we used trim-and-fill method to correct
the bias, which did not alter the significant positive asso-
ciation between insomnia and depression risk.
Based on our findings, we suggest that future research
in this field is warranted, especially the long-term pro-
spective cohort studies about the association between in-
dividual insomnia symptoms and depression. In addition,
more interventional studies are necessary to explore the
underlying mechanisms that link insomnia and depression.
Conclusions
In conclusion, this meta-analysis supports the hypoth-
esis that insomnia is associated with an increased risk
of depression. Considering the increasing prevalence of
insomnia worldwide and the heavy burdens of depression,
the results of our study provide practical and valuable
clues for the prevention of depression and the study of its
etiology.
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